---
Hematological Oncology,Volume 36, Issue 1, Page 15-23, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 27, 2017 Category: Hematology Source Type: research
Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients
In this study, we demonstrated that being underweight and obese were independent prognostic factors compared with being normal weight. In female patients, BMI had a different impact on the prognosis of young and elderly patients, whereas in male patients, there was no difference in the effect of BMI on prognosis according to age. (Source: Hematological Oncology)
Source: Hematological Oncology - April 27, 2017 Category: Hematology Authors: Yusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, Miho Tamura, Takeshi Sawada, Yasushi Omuro, Tsunekazu Hishima, Yoshiharu Maeda Tags: ORIGINAL RESEARCH ARTICLE Source Type: research
Interphase FISH for BCR ‐ABL1 rearrangement on neutrophils: A decisive tool to discriminate a lymphoid blast crisis of chronic myeloid leukemia from a de novo BCR‐ABL1 positive acute lymphoblastic leukemia
Hematological Oncology,Volume 36, Issue 1, Page 344-348, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 25, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 344-348, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 25, 2017 Category: Hematology Source Type: research
Age ‐related health care disparities in multiple myeloma
Hematological Oncology,Volume 36, Issue 1, Page 224-231, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 21, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 224-231, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 21, 2017 Category: Hematology Source Type: research
Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
Hematological Oncology,Volume 36, Issue 1, Page 320-323, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 11, 2017 Category: Hematology Source Type: research
Complete metabolic response (CMR) in positron emission tomography –computed tomography (PET‐CT) scans may have prognostic significance in patients with marginal zone lymphomas (MZL)
Hematological Oncology,Volume 36, Issue 1, Page 56-61, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 11, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 320-323, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 11, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 56-61, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 11, 2017 Category: Hematology Source Type: research
Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
We present a case of a patient, negative for HIV and HHV‐8, who had an unsuccessful surgical intervention and no response to radiotherapy and chemotherapy. He had severe paraneoplastic pemphigus and was treated with tocilizumab, an anti‐interleukin‐6 receptor monoclonal antibody that has demonstrated good response rates in multicentric Castleman disease but demonstrated no clinical response despite 2 months of treatment. Our report is the first to describe a lack of response to tocilizumab in the rare setting of refractory UCD and discuss potential for distinct disease biology. (Source: Hematological Oncology)
Source: Hematological Oncology - April 11, 2017 Category: Hematology Authors: Muhammad Bilal Abid, Rachel Peck, Muhammad Abbas Abid, Wesam Al ‐Sakkaf, Yuening Zhang, Giles S. Dunnill, Konrad Staines, Iara‐Maria Sequeiros, Lisa Lowry Tags: CASE REPORT Source Type: research
Diagnosis and management of neuropathies associated with plasma cell dyscrasias
Hematological Oncology,Volume 36, Issue 1, Page 3-14, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 10, 2017 Category: Hematology Source Type: research
---
Hematological Oncology,Volume 36, Issue 1, Page 3-14, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 10, 2017 Category: Hematology Source Type: research
How in ‐depth histological look may allow challenging diagnosis: The case of a primary in situ mantle cell neoplasm of the appendix
Hematological Oncology,Volume 36, Issue 1, Page 376-378, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 9, 2017 Category: Hematology Source Type: research
Long ‐term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population‐based, single‐center study with median follow‐up of 13.7 years
Hematological Oncology,Volume 36, Issue 1, Page 217-223, February 2018. (Source: Hematological Oncology)
Source: Hematological Oncology - April 9, 2017 Category: Hematology Source Type: research
